On July 5, GuoLongHui reported that French state-owned investment company Bpifrance is considering joining the bidding for Sanofi's consumer healthcare business. Sanofi is in talks to divest its consumer healthcare division, with options including a complete sale. Private equity funds such as Bain Capital and Cinven have expressed interest in acquiring relevant assets, while merge fund PAI Partners also intends to participate in the bidding. The market estimates that the transaction value involved in the sale could be as high as $20 billion. Bpifrance's managing director, Jose Gonzalo, revealed on Thursday to reporters that the company is discussing with multiple funds and researching the possibility of forming a joint bid for Sanofi's division. Sources said that Sanofi is inclined to sell the business to local buyers in France. CEO Paul Hudson said on Wednesday that the company is in contact with various consortia and exploring different options.
法国政府投资公司拟竞购赛诺菲健护业务 交易价值或高达200亿美元
French government investment company plans to compete for the acquisition of Sanofi healthcare business with a transaction value of up to 20 billion US dollars.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.